#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

White matter lesion Systemic sclerosis pulmonary Malignant oligodendroglioma Extra-osseous Ewing's sarcoma metastatic Colorectal adenocarcinoma Leiomyosarcoma metastatic Atopic keratoconjunctivitis Immune-mediated myasthenia gravis Tourette's disorder Juvenile psoriatic arthritis Soft tissue necrosis Erythema Ocular lymphoma Congenital cystic kidney disease Retinopathy proliferative More trials…
Learn about Rare Diseases

Mantle cell lymphoma stage IV Primary biliary cholangitis Waldenstrom’s macroglobulinaemia refractory – Basic Information VEXAS syndrome – Trials in Disease Mastocytosis Combined immunodeficiency – Life with Disease Ewing’s sarcoma – Life with Disease Langerhans cell sarcoma Primary biliary cholangitis – Trials in Disease Acute respiratory distress syndrome – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Nvl-655 Golexanolone Enmetazobactam Lovastatin Vonicog Alfa Iph5201 Terlipressin Acetate Fenoterol Hydrobromide Abc-23B-116 Rezafungin Acetate Safinamide Ly3484356 Human Coagulation Factor Ix Selpercatinib Daratumumab VERTEPORFIN Thiamine Hydrochloride Molidustat Sodium Teriparatide XELAFASLATIDE More therapies…

Learn about Your Condition

Colorectal cancer Asplenia Rett syndrome Glomerulonephritis acute Multiple sclerosis Merycism Ovarian cancer stage III Embolism Immune-mediated enterocolitis Pleural mesothelioma malignant Measles Skin papilloma Vasospasm Univentricular heart Small intestine adenocarcinoma More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Lobular breast carcinoma in situ

Comparison of Low-Dose Exemestane versus Low-Dose Tamoxifen for Breast Cancer Prevention in Postmenopausal Women at High Risk

Recruiting

2 1 1 1
Investigated Drugs:
- Exemestane
- Tamoxifen Citrate
Diagnostic Accuracy of [68Ga]FAPI-46 PET/CT for Detecting Metastatic Lesions in Patients with Invasive Lobular Breast Cancer

Not yet recruiting

2 1 1
Investigated Diseases:
- Invasive lobular breast carcinoma
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Lobular breast carcinoma in situ

Comparison of Low-Dose Exemestane versus Low-Dose Tamoxifen for Breast Cancer Prevention in Postmenopausal Women at High Risk

Diagnostic Accuracy of [68Ga]FAPI-46 PET/CT for Detecting Metastatic Lesions in Patients with Invasive Lobular Breast Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies